Polymer Drug Conjugates Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 09-Nov-2021
No. of pages: 105

This report contains market size and forecasts of Polymer Drug Conjugates in global, including the following market information:

Global Polymer Drug Conjugates Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Polymer Drug Conjugates Market Sales, 2016-2021, 2022-2027, (K Pcs)

Global top five Polymer Drug Conjugates companies in 2020 (%)

The global Polymer Drug Conjugates market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Polymer Drug Conjugates manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Polymer Drug Conjugates Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

Global Polymer Drug Conjugates Market Segment Percentages, By Type, 2020 (%)

- Polymer-Dox Conjugates

- Polymer-Paclitaxel Conjugates

- Polymer-Camptothecin Conjugates

- Polymer-Platinate Conjugates

Global Polymer Drug Conjugates Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

Global Polymer Drug Conjugates Market Segment Percentages, By Application, 2020 (%)

- Cancer Treatment

- Leukmia

- Hepatitis

- Others

Global Polymer Drug Conjugates Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

Global Polymer Drug Conjugates Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Polymer Drug Conjugates revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Polymer Drug Conjugates revenues share in global market, 2020 (%)

Key companies Polymer Drug Conjugates sales in global market, 2016-2021 (Estimated), (K Pcs)

Key companies Polymer Drug Conjugates sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- 3S Bio

- Abeona Therapeutics

- Abramson Cancer Center

- Access Pharmaceuticals

- Adama

- Eyetech

- Ferring

- Flamel Technologies

- Genentech

- GlaxoSmithKline

- Gowan

- Gynecologic Oncology Group Foundation

- JenKem Technology

- Landec

- Lipotek

Polymer Drug Conjugates Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Polymer Drug Conjugates Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polymer Drug Conjugates Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polymer Drug Conjugates Overall Market Size
2.1 Global Polymer Drug Conjugates Market Size: 2021 VS 2027
2.2 Global Polymer Drug Conjugates Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Polymer Drug Conjugates Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Polymer Drug Conjugates Players in Global Market
3.2 Top Global Polymer Drug Conjugates Companies Ranked by Revenue
3.3 Global Polymer Drug Conjugates Revenue by Companies
3.4 Global Polymer Drug Conjugates Sales by Companies
3.5 Global Polymer Drug Conjugates Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Polymer Drug Conjugates Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Polymer Drug Conjugates Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polymer Drug Conjugates Players in Global Market
3.8.1 List of Global Tier 1 Polymer Drug Conjugates Companies
3.8.2 List of Global Tier 2 and Tier 3 Polymer Drug Conjugates Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Polymer Drug Conjugates Market Size Markets, 2021 & 2027
4.1.2 Polymer-Dox Conjugates
4.1.3 Polymer-Paclitaxel Conjugates
4.1.4 Polymer-Camptothecin Conjugates
4.1.5 Polymer-Platinate Conjugates
4.2 By Type - Global Polymer Drug Conjugates Revenue & Forecasts
4.2.1 By Type - Global Polymer Drug Conjugates Revenue, 2016-2021
4.2.2 By Type - Global Polymer Drug Conjugates Revenue, 2022-2027
4.2.3 By Type - Global Polymer Drug Conjugates Revenue Market Share, 2016-2027
4.3 By Type - Global Polymer Drug Conjugates Sales & Forecasts
4.3.1 By Type - Global Polymer Drug Conjugates Sales, 2016-2021
4.3.2 By Type - Global Polymer Drug Conjugates Sales, 2022-2027
4.3.3 By Type - Global Polymer Drug Conjugates Sales Market Share, 2016-2027
4.4 By Type - Global Polymer Drug Conjugates Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Polymer Drug Conjugates Market Size, 2021 & 2027
5.1.2 Cancer Treatment
5.1.3 Leukmia
5.1.4 Hepatitis
5.1.5 Others
5.2 By Application - Global Polymer Drug Conjugates Revenue & Forecasts
5.2.1 By Application - Global Polymer Drug Conjugates Revenue, 2016-2021
5.2.2 By Application - Global Polymer Drug Conjugates Revenue, 2022-2027
5.2.3 By Application - Global Polymer Drug Conjugates Revenue Market Share, 2016-2027
5.3 By Application - Global Polymer Drug Conjugates Sales & Forecasts
5.3.1 By Application - Global Polymer Drug Conjugates Sales, 2016-2021
5.3.2 By Application - Global Polymer Drug Conjugates Sales, 2022-2027
5.3.3 By Application - Global Polymer Drug Conjugates Sales Market Share, 2016-2027
5.4 By Application - Global Polymer Drug Conjugates Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Polymer Drug Conjugates Market Size, 2021 & 2027
6.2 By Region - Global Polymer Drug Conjugates Revenue & Forecasts
6.2.1 By Region - Global Polymer Drug Conjugates Revenue, 2016-2021
6.2.2 By Region - Global Polymer Drug Conjugates Revenue, 2022-2027
6.2.3 By Region - Global Polymer Drug Conjugates Revenue Market Share, 2016-2027
6.3 By Region - Global Polymer Drug Conjugates Sales & Forecasts
6.3.1 By Region - Global Polymer Drug Conjugates Sales, 2016-2021
6.3.2 By Region - Global Polymer Drug Conjugates Sales, 2022-2027
6.3.3 By Region - Global Polymer Drug Conjugates Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Polymer Drug Conjugates Revenue, 2016-2027
6.4.2 By Country - North America Polymer Drug Conjugates Sales, 2016-2027
6.4.3 US Polymer Drug Conjugates Market Size, 2016-2027
6.4.4 Canada Polymer Drug Conjugates Market Size, 2016-2027
6.4.5 Mexico Polymer Drug Conjugates Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Polymer Drug Conjugates Revenue, 2016-2027
6.5.2 By Country - Europe Polymer Drug Conjugates Sales, 2016-2027
6.5.3 Germany Polymer Drug Conjugates Market Size, 2016-2027
6.5.4 France Polymer Drug Conjugates Market Size, 2016-2027
6.5.5 U.K. Polymer Drug Conjugates Market Size, 2016-2027
6.5.6 Italy Polymer Drug Conjugates Market Size, 2016-2027
6.5.7 Russia Polymer Drug Conjugates Market Size, 2016-2027
6.5.8 Nordic Countries Polymer Drug Conjugates Market Size, 2016-2027
6.5.9 Benelux Polymer Drug Conjugates Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Polymer Drug Conjugates Revenue, 2016-2027
6.6.2 By Region - Asia Polymer Drug Conjugates Sales, 2016-2027
6.6.3 China Polymer Drug Conjugates Market Size, 2016-2027
6.6.4 Japan Polymer Drug Conjugates Market Size, 2016-2027
6.6.5 South Korea Polymer Drug Conjugates Market Size, 2016-2027
6.6.6 Southeast Asia Polymer Drug Conjugates Market Size, 2016-2027
6.6.7 India Polymer Drug Conjugates Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Polymer Drug Conjugates Revenue, 2016-2027
6.7.2 By Country - South America Polymer Drug Conjugates Sales, 2016-2027
6.7.3 Brazil Polymer Drug Conjugates Market Size, 2016-2027
6.7.4 Argentina Polymer Drug Conjugates Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Polymer Drug Conjugates Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Polymer Drug Conjugates Sales, 2016-2027
6.8.3 Turkey Polymer Drug Conjugates Market Size, 2016-2027
6.8.4 Israel Polymer Drug Conjugates Market Size, 2016-2027
6.8.5 Saudi Arabia Polymer Drug Conjugates Market Size, 2016-2027
6.8.6 UAE Polymer Drug Conjugates Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 3S Bio
7.1.1 3S Bio Corporate Summary
7.1.2 3S Bio Business Overview
7.1.3 3S Bio Polymer Drug Conjugates Major Product Offerings
7.1.4 3S Bio Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.1.5 3S Bio Key News
7.2 Abeona Therapeutics
7.2.1 Abeona Therapeutics Corporate Summary
7.2.2 Abeona Therapeutics Business Overview
7.2.3 Abeona Therapeutics Polymer Drug Conjugates Major Product Offerings
7.2.4 Abeona Therapeutics Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.2.5 Abeona Therapeutics Key News
7.3 Abramson Cancer Center
7.3.1 Abramson Cancer Center Corporate Summary
7.3.2 Abramson Cancer Center Business Overview
7.3.3 Abramson Cancer Center Polymer Drug Conjugates Major Product Offerings
7.3.4 Abramson Cancer Center Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.3.5 Abramson Cancer Center Key News
7.4 Access Pharmaceuticals
7.4.1 Access Pharmaceuticals Corporate Summary
7.4.2 Access Pharmaceuticals Business Overview
7.4.3 Access Pharmaceuticals Polymer Drug Conjugates Major Product Offerings
7.4.4 Access Pharmaceuticals Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.4.5 Access Pharmaceuticals Key News
7.5 Adama
7.5.1 Adama Corporate Summary
7.5.2 Adama Business Overview
7.5.3 Adama Polymer Drug Conjugates Major Product Offerings
7.5.4 Adama Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.5.5 Adama Key News
7.6 Eyetech
7.6.1 Eyetech Corporate Summary
7.6.2 Eyetech Business Overview
7.6.3 Eyetech Polymer Drug Conjugates Major Product Offerings
7.6.4 Eyetech Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.6.5 Eyetech Key News
7.7 Ferring
7.7.1 Ferring Corporate Summary
7.7.2 Ferring Business Overview
7.7.3 Ferring Polymer Drug Conjugates Major Product Offerings
7.4.4 Ferring Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.7.5 Ferring Key News
7.8 Flamel Technologies
7.8.1 Flamel Technologies Corporate Summary
7.8.2 Flamel Technologies Business Overview
7.8.3 Flamel Technologies Polymer Drug Conjugates Major Product Offerings
7.8.4 Flamel Technologies Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.8.5 Flamel Technologies Key News
7.9 Genentech
7.9.1 Genentech Corporate Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech Polymer Drug Conjugates Major Product Offerings
7.9.4 Genentech Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.9.5 Genentech Key News
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporate Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Polymer Drug Conjugates Major Product Offerings
7.10.4 GlaxoSmithKline Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.10.5 GlaxoSmithKline Key News
7.11 Gowan
7.11.1 Gowan Corporate Summary
7.11.2 Gowan Polymer Drug Conjugates Business Overview
7.11.3 Gowan Polymer Drug Conjugates Major Product Offerings
7.11.4 Gowan Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.11.5 Gowan Key News
7.12 Gynecologic Oncology Group Foundation
7.12.1 Gynecologic Oncology Group Foundation Corporate Summary
7.12.2 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Business Overview
7.12.3 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Major Product Offerings
7.12.4 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.12.5 Gynecologic Oncology Group Foundation Key News
7.13 JenKem Technology
7.13.1 JenKem Technology Corporate Summary
7.13.2 JenKem Technology Polymer Drug Conjugates Business Overview
7.13.3 JenKem Technology Polymer Drug Conjugates Major Product Offerings
7.13.4 JenKem Technology Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.13.5 JenKem Technology Key News
7.14 Landec
7.14.1 Landec Corporate Summary
7.14.2 Landec Business Overview
7.14.3 Landec Polymer Drug Conjugates Major Product Offerings
7.14.4 Landec Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.14.5 Landec Key News
7.15 Lipotek
7.15.1 Lipotek Corporate Summary
7.15.2 Lipotek Business Overview
7.15.3 Lipotek Polymer Drug Conjugates Major Product Offerings
7.15.4 Lipotek Polymer Drug Conjugates Sales and Revenue in Global (2016-2021)
7.15.5 Lipotek Key News
8 Global Polymer Drug Conjugates Production Capacity, Analysis
8.1 Global Polymer Drug Conjugates Production Capacity, 2016-2027
8.2 Polymer Drug Conjugates Production Capacity of Key Manufacturers in Global Market
8.3 Global Polymer Drug Conjugates Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Polymer Drug Conjugates Supply Chain Analysis
10.1 Polymer Drug Conjugates Industry Value Chain
10.2 Polymer Drug Conjugates Upstream Market
10.3 Polymer Drug Conjugates Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polymer Drug Conjugates Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Polymer Drug Conjugates in Global Market
Table 2. Top Polymer Drug Conjugates Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Polymer Drug Conjugates Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Polymer Drug Conjugates Revenue Share by Companies, 2016-2021
Table 5. Global Polymer Drug Conjugates Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Polymer Drug Conjugates Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Polymer Drug Conjugates Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Polymer Drug Conjugates Product Type
Table 9. List of Global Tier 1 Polymer Drug Conjugates Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Polymer Drug Conjugates Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Polymer Drug Conjugates Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Polymer Drug Conjugates Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Polymer Drug Conjugates Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Polymer Drug Conjugates Sales (K Pcs), 2016-2021
Table 15. By Type - Global Polymer Drug Conjugates Sales (K Pcs), 2022-2027
Table 16. By Application - Global Polymer Drug Conjugates Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Polymer Drug Conjugates Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Polymer Drug Conjugates Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Polymer Drug Conjugates Sales (K Pcs), 2016-2021
Table 20. By Application - Global Polymer Drug Conjugates Sales (K Pcs), 2022-2027
Table 21. By Region - Global Polymer Drug Conjugates Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Polymer Drug Conjugates Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Polymer Drug Conjugates Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Polymer Drug Conjugates Sales (K Pcs), 2016-2021
Table 25. By Region - Global Polymer Drug Conjugates Sales (K Pcs), 2022-2027
Table 26. By Country - North America Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Polymer Drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Polymer Drug Conjugates Sales, (K Pcs), 2016-2021
Table 29. By Country - North America Polymer Drug Conjugates Sales, (K Pcs), 2022-2027
Table 30. By Country - Europe Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Polymer Drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Polymer Drug Conjugates Sales, (K Pcs), 2016-2021
Table 33. By Country - Europe Polymer Drug Conjugates Sales, (K Pcs), 2022-2027
Table 34. By Region - Asia Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Polymer Drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Polymer Drug Conjugates Sales, (K Pcs), 2016-2021
Table 37. By Region - Asia Polymer Drug Conjugates Sales, (K Pcs), 2022-2027
Table 38. By Country - South America Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Polymer Drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Polymer Drug Conjugates Sales, (K Pcs), 2016-2021
Table 41. By Country - South America Polymer Drug Conjugates Sales, (K Pcs), 2022-2027
Table 42. By Country - Middle East & Africa Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Polymer Drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Polymer Drug Conjugates Sales, (K Pcs), 2016-2021
Table 45. By Country - Middle East & Africa Polymer Drug Conjugates Sales, (K Pcs), 2022-2027
Table 46. 3S Bio Corporate Summary
Table 47. 3S Bio Polymer Drug Conjugates Product Offerings
Table 48. 3S Bio Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 49. Abeona Therapeutics Corporate Summary
Table 50. Abeona Therapeutics Polymer Drug Conjugates Product Offerings
Table 51. Abeona Therapeutics Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 52. Abramson Cancer Center Corporate Summary
Table 53. Abramson Cancer Center Polymer Drug Conjugates Product Offerings
Table 54. Abramson Cancer Center Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 55. Access Pharmaceuticals Corporate Summary
Table 56. Access Pharmaceuticals Polymer Drug Conjugates Product Offerings
Table 57. Access Pharmaceuticals Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 58. Adama Corporate Summary
Table 59. Adama Polymer Drug Conjugates Product Offerings
Table 60. Adama Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 61. Eyetech Corporate Summary
Table 62. Eyetech Polymer Drug Conjugates Product Offerings
Table 63. Eyetech Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 64. Ferring Corporate Summary
Table 65. Ferring Polymer Drug Conjugates Product Offerings
Table 66. Ferring Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 67. Flamel Technologies Corporate Summary
Table 68. Flamel Technologies Polymer Drug Conjugates Product Offerings
Table 69. Flamel Technologies Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 70. Genentech Corporate Summary
Table 71. Genentech Polymer Drug Conjugates Product Offerings
Table 72. Genentech Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 73. GlaxoSmithKline Corporate Summary
Table 74. GlaxoSmithKline Polymer Drug Conjugates Product Offerings
Table 75. GlaxoSmithKline Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 76. Gowan Corporate Summary
Table 77. Gowan Polymer Drug Conjugates Product Offerings
Table 78. Gowan Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 79. Gynecologic Oncology Group Foundation Corporate Summary
Table 80. Gynecologic Oncology Group Foundation Polymer Drug Conjugates Product Offerings
Table 81. Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 82. JenKem Technology Corporate Summary
Table 83. JenKem Technology Polymer Drug Conjugates Product Offerings
Table 84. JenKem Technology Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 85. Landec Corporate Summary
Table 86. Landec Polymer Drug Conjugates Product Offerings
Table 87. Landec Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 88. Lipotek Corporate Summary
Table 89. Lipotek Polymer Drug Conjugates Product Offerings
Table 90. Lipotek Polymer Drug Conjugates Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 91. Polymer Drug Conjugates Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2019-2021 (K Pcs)
Table 92. Global Polymer Drug Conjugates Capacity Market Share of Key Manufacturers, 2019-2021
Table 93. Global Polymer Drug Conjugates Production by Region, 2016-2021 (K Pcs)
Table 94. Global Polymer Drug Conjugates Production by Region, 2022-2027 (K Pcs)
Table 95. Polymer Drug Conjugates Market Opportunities & Trends in Global Market
Table 96. Polymer Drug Conjugates Market Drivers in Global Market
Table 97. Polymer Drug Conjugates Market Restraints in Global Market
Table 98. Polymer Drug Conjugates Raw Materials
Table 99. Polymer Drug Conjugates Raw Materials Suppliers in Global Market
Table 100. Typical Polymer Drug Conjugates Downstream
Table 101. Polymer Drug Conjugates Downstream Clients in Global Market
Table 102. Polymer Drug Conjugates Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Polymer Drug Conjugates Segment by Type
Figure 2. Polymer Drug Conjugates Segment by Application
Figure 3. Global Polymer Drug Conjugates Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Polymer Drug Conjugates Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Polymer Drug Conjugates Revenue, 2016-2027 (US$, Mn)
Figure 7. Polymer Drug Conjugates Sales in Global Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Polymer Drug Conjugates Revenue in 2020
Figure 9. By Type - Global Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 10. By Type - Global Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 11. By Type - Global Polymer Drug Conjugates Price (USD/Pcs), 2016-2027
Figure 12. By Application - Global Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 13. By Application - Global Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 14. By Application - Global Polymer Drug Conjugates Price (USD/Pcs), 2016-2027
Figure 15. By Region - Global Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 16. By Region - Global Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 17. By Country - North America Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 18. By Country - North America Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 19. US Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 24. Germany Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 25. France Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 33. China Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 37. India Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 39. By Country - South America Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 40. Brazil Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Polymer Drug Conjugates Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Polymer Drug Conjugates Sales Market Share, 2016-2027
Figure 44. Turkey Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Polymer Drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 48. Global Polymer Drug Conjugates Production Capacity (K Pcs), 2016-2027
Figure 49. The Percentage of Production Polymer Drug Conjugates by Region, 2020 VS 2027
Figure 50. Polymer Drug Conjugates Industry Value Chain
Figure 51. Marketing Channels
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs